(Q44530878)

3 December 2017

Effects of HIV disease on lipid, glucose and insulin levels: results from a large antiretroviral-naive cohort (English)

1 reference

3 December 2017

0 references

1 reference

El-Sadr WM

1

1 reference

3 December 2017

Mullin CM

2

1 reference

3 December 2017

Carr A

3

1 reference

3 December 2017

Gibert C

4

1 reference

3 December 2017

Rappoport C

5

1 reference

3 December 2017

Visnegarwala F

6

1 reference

3 December 2017

Grunfeld C

7

1 reference

3 December 2017

Raghavan SS

8

1 reference

3 December 2017

1 March 2005

1 reference

3 December 2017

1 reference

3 December 2017

6

1 reference

3 December 2017

114-121

1 reference

3 December 2017

2

1 reference

Hypertriglyceridemia in the acquired immunodeficiency syndrome

3 December 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00273.X

Insulin sensitivity and insulin clearance in human immunodeficiency virus-infected men

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00273.X

Diagnosis, prediction, and natural course of HIV-1 protease-inhibitor-associated lipodystrophy, hyperlipidaemia, and diabetes mellitus: a cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00273.X

Fat distribution evaluated by computed tomography and metabolic abnormalities in patients undergoing antiretroviral therapy: preliminary results of the LIPOCO study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00273.X

A review on ethnic differences in plasma triglycerides and high-density-lipoprotein cholesterol: is the lipid pattern the key factor for the low coronary heart disease rate in people of African origin?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00273.X

Ethnic differences in coronary atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00273.X

Effect of ritonavir on lipids and post-heparin lipase activities in normal subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00273.X

Metabolic effects of indinavir in healthy HIV-seronegative men

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00273.X

Impact of HIV infection and HAART on serum lipids in men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00273.X

A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00273.X

Impaired glucose tolerance, beta cell function and lipid metabolism in HIV patients under treatment with protease inhibitors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00273.X

Hyperinsulinemia as an independent risk factor for ischemic heart disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00273.X

Metabolic abnormalities and cardiovascular disease risk factors in adults with human immunodeficiency virus infection and lipodystrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00273.X

Cardiovascular and cerebrovascular events in patients treated for human immunodeficiency virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1468-1293.2005.00273.X

10.1111/J.1468-1293.2005.00273.X

21 January 2018

Identifiers

DOI

1 reference

3 December 2017

1 reference